#1 out of 1
health23h ago
New data shows 5x growth in medical crowdfunding across Europe
- WhyDonate reports a fivefold rise in European medical crowdfunding from 2021 to 2025, with campaigns generating €3.1 million in funds.
- The report analyzed over 11,000 health campaigns and 164,536 donations from 2021–2025 across Europe.
- Gaps in national reimbursement systems are linked to access delays for new cancer therapies across Europe.
- The study highlights paediatric cancer, rare diseases, and unreimbursed treatments as common crowdfunding targets.
- Crowdfunding is described as a practical means to access treatment when other funding options are limited or unavailable.
- The report notes wide variation in treatment access timelines, ranging from under 100 days to about 900 days across Europe.
- Europe accounts for a significant share of global medical crowdfunding according to the report.
- The full WhyDonate Medical Crowdfunding Report 2026 is available for further details.
- Gaps between approval and reimbursement drive demand for funding in Europe.
- The study highlights conditions frequently funded, including paediatric cancer and multiple sclerosis.
Vote 0